Water Logos

scientist-with-test-tubes-pharma-research-banner.jpg

Enhance Your Nitrosamine Risk Assessment

Explore key methods and insights to improve contaminant analysis with precision and reliability

Learn how Shinogi Pharma Co., Ltd prepared a system offering total CDMO support for nitrosamine analysis after reacting to the stringent detection limits at or below 0.3 ppm and acceptable limit for nitrosamines in sartan API's.

Key Learning Points:

  • Detailed Risk Evaluation: Gain in-depth understanding of evaluating nitrosamine contamination with proven methodologies.
  • Advanced Detection Tools: Learn how the ACQUITY UPLC I-Class PLUS and the Xevo TQ-XS Mass Spectrometer enhance accuracy in nitrosamine detection.
  • Best Practices: Discover actionable strategies to ensure compliance and safety in lab analyses.

Discover the full potential of your lab’s nitrosamine analysis—Download the case study to learn more about how you can stay ahead in compliance and accuracy.